慢性肾脏病代谢性酸中毒患者对钠的耐受性:伴随阴离子是否重要?
该综述探讨慢性肾脏病合并代谢性酸中毒患者补充钠盐时,伴随阴离子(碳酸氢根或枸橼酸根 vs 氯)对血压和钠潴留的影响。文献分析提示,在严格限制膳食氯化钠(约10 mEq/d)时,碳酸氢钠不升高血压或导致钠潴留;但无严格限盐时,无论伴随何种阴离子,额外钠负荷均升高血压并潴留钠。
要点
- 严格限盐(约10 mEq/d)下碳酸氢钠不升高血压或钠潴留。
- 无严格限盐时,碳酸氢钠仍升高血压并导致钠潴留。
- 临床研究常排除高血压失控、心衰、容量负荷过重患者。
核心结论
- 除非患者能耐受几乎不含氯化钠的饮食,否则额外补充的钠无论伴随何种阴离子,均升高血压并导致钠潴留。
研究设计与样本
- 文献综述,分析慢性肾脏病代谢性酸中毒患者补充不同钠盐对血压和钠潴留的影响。
主要发现
- 在严格限制膳食氯化钠(约10 mEq/d)时,碳酸氢钠不升高血压或导致钠潴留。
- 无严格限盐时,碳酸氢钠升高血压并导致钠潴留。
- 既往研究常排除高血压控制不佳、充血性心力衰竭、容量负荷过重或水肿等钠敏感合并症患者。
临床怎么用
- 对慢性肾脏病代谢性酸中毒患者使用碳酸氢钠或枸橼酸钠时,应评估钠摄入量及钠敏感合并症。
- 若无法严格限盐,需监测血压、体重和水肿以评估钠潴留风险。
局限性
- 严格限盐(约10 mEq/d)仅在临床研究环境中可行,常规临床难以实现。
- 现有研究常排除钠敏感合并症患者,结果外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Patients with chronic kidney disease (CKD) continue to produce endogenous acids but have a reduction in net acid excretion, resulting in a primary decrease in serum bicarbonate concentration, which is termed chronic metabolic acidosis. Recent prospective studies, along with retrospective cohort analyses, demonstrate a higher risk for CKD progression with untreated metabolic acidosis. To normalize serum bicarbonate levels, acidemic patients are often treated with sodium bicarbonate (NaHCO3) or sodium citrate, which have been shown to slow the progression of CKD. However, studies using this approach have routinely excluded patients with common sodium-sensitive comorbid conditions, such as poorly controlled hypertension, congestive heart failure, volume overload, or edema. This article examines the effect of the anion that accompanies sodium delivered with these therapies. Do the negative effects on blood pressure (BP) and sodium retention, as measured by an increase in edema, weight gain, and congestive heart failure, observed with oral administration of sodium chloride (NaCl) differ when a similar amount of sodium is given with bicarbonate or citrate in this patient population? A review of the literature suggests that NaHCO3 does not increase BP or sodium retention when administered to patients with CKD during a concurrent severe NaCl dietary restriction (∼10 mEq/d). However, this degree of NaCl restriction is feasible only under strict control in clinical research environments. In contrast, when NaHCO3 is given to patients without severe dietary NaCl restriction, there is an increase in BP and sodium retention. Thus, unless patients with CKD can tolerate a diet virtually devoid of NaCl, additional sodium, regardless of the accompanying anion, appears to increase BP and sodium retention.
引用
- Bushinsky DA. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter? Am J Kidney Dis. 2018. PMID: 30518477. doi:10.1053/j.ajkd.2018.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。